Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Lauren K. MacAfee"'
Autor:
Catalina N. Rey, Sarah H. Heil, Gary J. Badger, Anne Dougherty, Heidi S. Melbostad, Stacey C. Sigmon, Lauren K. MacAfee
Publikováno v:
Subst Use Misuse
BACKGROUND: Rates of unintended pregnancy among women receiving medication treatment for opioid use disorder (mOUD) are high, likely due in part to low rates of contraceptive use. Lack of knowledge about contraception may be contributing to inadequat
Autor:
Heidi S. Melbostad, Gary J. Badger, Stacey C. Sigmon, Anne Dougherty, Catalina N. Rey, Lauren K. MacAfee, Deborah Wachtel, Sarah H. Heil
Publikováno v:
Contraception
Objectives To evaluate perceptions of long-acting reversible contraceptives (LARC) among women receiving medication for opioid use disorder. Study design Cross-sectional survey of 200 women receiving medication for opioid use disorder in Vermont. Res
Autor:
Heidi S. Melbostad, Deborah S. Wachtel, Kerstin A. Lipke, Gary J. Badger, Alexis K. Matusiewicz, Catalina N. Rey, Lauren K. MacAfee, Anne K. Dougherty, Sarah H. Heil
Publikováno v:
Contraception
OBJECTIVE(S): To characterize for the first time the side effect profile, safety, and tolerability of hormonal contraception among women receiving opioid-agonist therapy. STUDY DESIGN: We conducted a secondary analysis of data collected from particip
Autor:
Madelyn McCartin, Lindsay M. Cannon, Roxanne F. Harfmann, Vanessa K. Dalton, Lauren K. MacAfee, Yasamin Kusunoki
Publikováno v:
Women's health issues : official publication of the Jacobs Institute of Women's Health. 32(6)
We aimed to examine the role of perceived and direct stigma on access to reproductive health services among women in treatment for substance use disorders in Michigan.We draw on self-interview data from a cross-sectional study of female patients aged
Autor:
Sarah Prager, Lemi Belay Tolu, Tesfaye H. Tufa, Ferid Abas, Lauren K. MacAfee, Chavi Kahn, Jason D. Bell
Publikováno v:
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and ObstetricsREFERENCES. 153(1)
Objective To determine the efficacy and safety of intra-cardiac lidocaine administration to induce fetal demise prior to second trimester medication abortion in a teaching hospital in Addis Ababa, Ethiopia. Study design We performed a retrospective c
Autor:
Lauren K. MacAfee, Lindsay M Cannon, Vanessa K. Dalton, Roxanne F. Harfmann, Yasamin Kusunoki, G. Kolenic, Mishka Terplan
Publikováno v:
Obstetrics and gynecology. 135(2)
OBJECTIVE To evaluate the sexual and reproductive health characteristics of women in treatment for opioid use disorder in Michigan and explore services provided and desired. METHODS We conducted a cross-sectional study of female patients aged 18-50 y
Publikováno v:
Journal of Substance Abuse Treatment. 89:67-74
Objective To describe differences in geographic, demographic, treatment, and substance use characteristics by pharmacotherapy receipt among pregnant women entering publically funded treatment for opioid use disorder (OUD) in the United States. Method
Autor:
Catalina N. Rey, Donald S. Shepard, Lauren K. MacAfee, Heidi S. Melbostad, Gary J. Badger, Stacey C. Sigmon, Alexis K. Matusiewicz, Sarah H. Heil, Stephen T. Higgins
Publikováno v:
JAMA Psychiatry
IMPORTANCE: Rates of in utero opioid exposure continue to increase in the US. Nearly all of these pregnancies are unintended but there has been little intervention research addressing this growing and costly public health problem. OBJECTIVE: To test
Autor:
Leah Minadeo, Vanessa K. Dalton, Roxanne F. Harfmann, Yasamin Kusunoki, Lauren K. MacAfee, Giselle E. Kolenic, Lindsay M Cannon
Publikováno v:
Substance usemisuse. 55(1)
Background: Women with substance use disorders have high rates of adverse sexual and reproductive health (SRH) outcomes, including unintended pregnancy, sexually transmitted infections, and...
Publikováno v:
Journal of addiction medicine. 13(3)
OBJECTIVES The aim of the study was to evaluate pregnancy intention, risk perception, and contraceptive utilization among women reporting substance use during pregnancy. METHODS Data were obtained from the 2009 to 2011 Tennessee Pregnancy Risk Assess